{
  "extracted_facts": [
    {
      "drug_name": "citalopram",
      "condition_name": "major depressive disorder",
      "relation": "TREATS",
      "outcome": "remission rate",
      "side_effects": [],
      "effect_size": "",
      "confidence_interval": "",
      "source_id": "Psychiatry",
      "section": "Difference in Treatment Outcome in Outpatients With Anxious Versus Nonanxious Depression: A STAR*D Report",
      "span": "A total of 2,876 adult outpatients with major depressive disorder, enrolled from 18 primary and 23 psychiatric care sites, received citalopram in Level 1 of STAR*D.",
      "confidence": 0.9
    },
    {
      "drug_name": "citalopram",
      "condition_name": "depression",
      "relation": "TREATS",
      "outcome": "symptom remission",
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null,
      "source_id": "Psychiatry",
      "section": "Intervention",
      "span": "The aim of citalopram treatment in Level 1 was to achieve symptom remission, which was defined as QIDS-C score â‰¤ 5.",
      "confidence": 0.9
    },
    {
      "drug_name": "citalopram",
      "condition_name": "depression",
      "relation": "IMPROVES",
      "outcome": "HAM-D score",
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null,
      "source_id": "Psychiatry",
      "section": "Main Outcome Measures",
      "span": "The primary outcome measure was the HAM-D score, obtained by research outcome assessors using telephone-based structured interviews at entry and exit from citalopram treatment.",
      "confidence": 0.9
    },
    {
      "drug_name": "citalopram",
      "condition_name": "depression",
      "relation": "IMPROVES",
      "outcome": "remission rate",
      "side_effects": [],
      "effect_size": "lower remission rates compared to nonanxious depression",
      "confidence_interval": null,
      "source_id": "Psychiatry",
      "section": "discussion",
      "span": "patients with anxious depression were less likely to respond or to remit with citalopram treatment than those with nonanxious depression",
      "confidence": 0.9
    },
    {
      "drug_name": "citalopram",
      "condition_name": "major depressive disorder",
      "relation": "TREATS",
      "outcome": "remission",
      "side_effects": [
        "worsening insomnia",
        "nervousness",
        "dryness of mouth",
        "constipation"
      ],
      "effect_size": null,
      "confidence_interval": null,
      "source_id": "Psychiatry",
      "section": "Patient Perspective",
      "span": "Ms. D was started on a course of antidepressant therapy with citalopram... After 6 weeks of combined treatment with citalopram and a benzodiazepine, Ms. D reported a significant improvement in all her symptoms, and remission was achieved at the end of the 10th week of treatment.",
      "confidence": 0.9
    },
    {
      "drug_name": "benzodiazepine",
      "condition_name": "insomnia and agitation",
      "relation": "TREATS",
      "outcome": "significant improvement",
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null,
      "source_id": "Psychiatry",
      "section": "Patient Perspective",
      "span": "a benzodiazepine was prescribed, which brought about a significant improvement in her insomnia and agitation.",
      "confidence": 0.9
    }
  ],
  "total_facts": 6,
  "extraction_timestamp": "2025-10-31T20:17:23.437728",
  "extraction_model": "gpt-4o"
}